Apogee Therapeutics CFO Sells 2,000 Shares
Reporter NameHenderson JaneRelationshipChief Financial Officer, 10% OwnerTypeSellAmount$130,000SEC FilingForm 4Jane Henderson, Chief Financial Officer and 10% owner of Apogee Therapeutics, sold 2,000 shares of common stock on November 14, 2025, at a price of $65.0 per share, totaling $130,000. Following the transaction, Henderson directly owns 197,871 shares of the company. The sale was executed under a Rule 10b5-1 trading plan adopted on September 27, 2024.SEC Filing: Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Nov. 14, 2025
| Reporter Name | Henderson Jane |
| Relationship | Chief Financial Officer, 10% Owner |
| Type | Sell |
| Amount | $130,000 |
| SEC Filing | Form 4 |
Jane Henderson, Chief Financial Officer and 10% owner of Apogee Therapeutics, sold 2,000 shares of common stock on November 14, 2025, at a price of $65.0 per share, totaling $130,000. Following the transaction, Henderson directly owns 197,871 shares of the company. The sale was executed under a Rule 10b5-1 trading plan adopted on September 27, 2024.
SEC Filing: Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Nov. 14, 2025
